Free Trial

This company has been marked as potentially delisted and may not be actively trading.

LAVA Therapeutics (LVTX) Institutional Ownership

LAVA Therapeutics logo

Institutional Ownership Changes (13F Filings) for LAVA Therapeutics (NASDAQ:LVTX)

Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$6.59M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$342.92K
Get LVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling LAVA Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LVTX Institutional Buying and Selling by Quarter

LAVA Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Citadel Advisors LLC53,308$83K0.0%-23.4%0.203%
11/14/2025Shay Capital LLC2,548,730$3.98M0.3%N/A9.689%
8/16/2025Lepercq De Neuflize Asset Management LLC31,000$41K0.0%+34.8%0.118%
8/15/2025Rangeley Capital LLC27,073$36K0.0%N/A0.103%
8/11/2025BML Capital Management LLC1,970,610$2.60M2.0%+0.5%7.491%
5/14/2025Bruce & Co. Inc.521,874$663K0.2%-32.4%1.984%
5/13/2025Lepercq De Neuflize Asset Management LLC23,000$29K0.0%N/A0.087%
5/8/2025XTX Topco Ltd24,307$31K0.0%N/A0.092%
5/7/2025BML Capital Management LLC1,960,610$2.49M1.9%N/A7.453%
2/17/2025Two Sigma Investments LP48,772$46K0.0%-52.5%0.186%
2/17/2025Sanofi1,919,455$1.83M1.0%N/A7.301%
2/17/2025Sphera Funds Management LTD.126,328$120K0.0%-13.7%0.481%
2/17/2025BNP Paribas Financial Markets41,800$40K0.0%N/A0.159%
11/20/2024Virtu Financial LLC19,103$32K0.0%N/A0.075%
11/15/2024Sphera Funds Management LTD.146,457$243K0.0%-60.2%0.000%
11/14/2024Walleye Capital LLC14,762$25K0.0%-42.5%0.000%
10/8/2024Pathway Financial Advisors LLC102,500$170K0.0%+70.8%0.404%
8/12/2024XTX Topco Ltd30,807$55K0.0%N/A0.122%
7/24/2024Pathway Financial Advisors LLC60,000$108K0.0%+328.6%0.000%
4/10/2024Pathway Financial Advisors LLC14,000$47K0.0%N/A0.000%
5/12/2023Bruce & Co. Inc.671,874$1.12M0.3%+571.9%2.650%
2/10/2023PNC Financial Services Group Inc.50,000$175K0.0%N/A0.197%
2/1/2023Bank of Montreal Can89,600$530K0.0%N/A0.353%
11/14/2022UBS Oconnor LLC75,000$343K0.0%N/A0.296%
10/28/2022Silverarc Capital Management LLC610,809$2.79M0.9%N/A2.409%
8/16/2022DAFNA Capital Management LLC128,335$379K0.1%-7.9%0.506%
8/15/2022Nantahala Capital Management LLC322,980$953K0.0%-3.3%1.274%
2/14/2022Point72 Asset Management L.P.119,152$655K0.0%-3.8%0.470%


LVTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LVTX shares?

During the previous two years, 14 institutional investors and hedge funds held shares of LAVA Therapeutics. The most heavily invested institutionals were Shay Capital LLC ($3.98M), BML Capital Management LLC ($2.60M), Sanofi ($1.83M), Bruce & Co. Inc. ($663K), Pathway Financial Advisors LLC ($170K), Sphera Funds Management LTD. ($120K), and Citadel Advisors LLC ($83K).Learn more on LAVA Therapeutics' institutional investors.

Which institutional investors have been buying LAVA Therapeutics' stock?

Of the 9 institutional investors that purchased LAVA Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Shay Capital LLC ($2.55M), BML Capital Management LLC ($1.97M), Sanofi ($1.92M), Pathway Financial Advisors LLC ($88.50K), XTX Topco Ltd ($55.11K), BNP Paribas Financial Markets ($41.80K), and Lepercq De Neuflize Asset Management LLC ($31K).

How much institutional buying is happening at LAVA Therapeutics?

Institutional investors have bought a total of 4,601,720 shares in the last 24 months. This purchase volume represents approximately $6.59M in transactions.

Which of LAVA Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold LAVA Therapeutics stock in the last 24 months: Bruce & Co. Inc. ($250K), and Citadel Advisors LLC ($16.30K).

How much institutional selling is happening at LAVA Therapeutics?

Institutional investors have sold a total of 266,296 shares in the last 24 months. This volume of shares sold represents approximately $342.92K in transactions.



This page (NASDAQ:LVTX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners